2022
Pang F, Dean R, Jensen I , Tehard B, Roze S, Olaye A, et al. The cost-effectiveness of atidarsagene autotemcel for the treatment of metachromatic leukodystrophy (MLD) in France. Abstract EE24 . ISPOR 2022.
View Abstract
Publication: Abstracts and Presentations
2021
Alexander W, Jensen I , Hathway J, Srivastava K, Cyr P, Batt K. Economic IMPACT of utilizing eptacog beta for the on-demand treatment of bleeding events among hemophilia patients with inhibitors. Abstract PBI11 . ISPOR 2021 Annual International Meeting.
View Abstract
Publication: Abstracts and Presentations
2020
Hathway J, Miller-Wilson L, Jensen I , Ozbay B, Regan C, Jena A, et al. 2020. Projecting total costs and health consequences of increasing mt-sDNA utilization for colorectal cancer screening from the payer and integrated delivery network perspectives. J Med Econ 23(6):581-592; doi: 10.1080/13696998.2020.1730123 .
View Abstract
Publication: Manuscripts
2014
Jensen IS , Halbert RJ, Thompson SF, Hennessy D, Pacconi S, McSweeney PA. Increased use of plerixafor in patients with multiple myeloma and non-Hodgkin lymphoma in the United States: A budgetary impact analysis. Abstract C14 . Academy of Managed Care Pharmacy 26th Annual Meeting & Expo 2014.
A Division of